These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12400584)

  • 1. Zelnorm: new treatment available for women with IBS.
    Nursing; 2002 Oct; 32(10):24, 26. PubMed ID: 12400584
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
    Horwitz BJ
    Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
    [No Abstract]   [Full Text] [Related]  

  • 3. [New drug for irritable bowel syndrome].
    Hennemann A
    Med Monatsschr Pharm; 2001 Apr; 24(4):106-8. PubMed ID: 11338633
    [No Abstract]   [Full Text] [Related]  

  • 4. Tegaserod maleate (Zelnorm) for IBS with constipation.
    Med Lett Drugs Ther; 2002 Sep; 44(1139):79-80. PubMed ID: 12237618
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 6. Contemporary thoughts on the treatment of irritable bowel syndrome.
    Giaquinta D
    Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
    [No Abstract]   [Full Text] [Related]  

  • 7. New drugs to treat irritable bowel syndrome being tested.
    Mayo Clin Health Lett; 2000 Mar; 18(3):4. PubMed ID: 10734837
    [No Abstract]   [Full Text] [Related]  

  • 8. Tegaserod and IBS: a perfect match?
    Grant Thompson W
    Gut; 2003 May; 52(5):621-2. PubMed ID: 12692042
    [No Abstract]   [Full Text] [Related]  

  • 9. Tegaserod and other serotonergic agents: what is the evidence?
    Chey WD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lotronex withdrawn from market.
    Harv Womens Health Watch; 2001 Feb; 8(6):6. PubMed ID: 11175468
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diets in irritable bowel syndrome--what do they really achieve? Please no culinary sadism!].
    Stiefelhagen P
    MMW Fortschr Med; 2001 Nov; 143(46):18. PubMed ID: 11759593
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic therapy for the irritable bowel syndrome.
    Talley NJ
    Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of tegaserod for the treatment of irritable bowel syndrome.
    Bergmann K
    J Clin Pharm Ther; 2003 Apr; 28(2):151-3; author reply 153. PubMed ID: 12713613
    [No Abstract]   [Full Text] [Related]  

  • 14. A pill turned bitter. How a quest for a blockbuster drug went fatally wrong.
    Shapiro JP
    US News World Rep; 2000 Dec; 129(23):54-6. PubMed ID: 11126059
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
    Olden K; DeGarmo RG; Jhingran P; Bagby B; Decker C; Markowitz M; Carter E; Bobbitt W; Dahdul A; DeCastro E; Gringeri L; Johanson J; Levinson L; Mula G; Poleynard G; Stoltz RR; Truesdale R; Young D;
    Am J Gastroenterol; 2002 Dec; 97(12):3139-46. PubMed ID: 12492201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment.
    Olden KW
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S3-7. PubMed ID: 12825862
    [No Abstract]   [Full Text] [Related]  

  • 17. By the way, doctor. I have irritable bowel syndrome, with frequent bloating and constipation. My doctor prescribed a six-week course of Zelnorm, which really helped. Is it safe to take long-term?
    Robb-Nicholson C
    Harv Womens Health Watch; 2005 May; 12(9):8. PubMed ID: 16047399
    [No Abstract]   [Full Text] [Related]  

  • 18. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
    Pasricha PJ
    Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201
    [No Abstract]   [Full Text] [Related]  

  • 19. [Meteospazmil and its place in treating patients with irritable bowel syndrome].
    Minushkin ON
    Eksp Klin Gastroenterol; 2002; (1):94-7. PubMed ID: 12271597
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA advisory panels recommend Lotronex be put back on market.
    Charatan F
    BMJ; 2002 May; 324(7345):1053. PubMed ID: 11993482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.